Lippomix Liposomal

The Source of Trusted Innovation
Bringing the original, cutting-edge, liposomal technology to superior pharmaceuticals and nutraceuticals
Their group of well experienced scientists and engineers invented three US patents for Liposome Manufacture, were instrumental in success of Phase I and Phase II Clinical Trials for a Liposome Encapsulated Diclofenac for the treatment of osteoarthritis. With the development of the new liposomal technology, Lippomix soon become the trusted source for pharmaceuticals and nutraceuticals.
The demand for efficient, effective natural supplements quickly escalated. In order to maintain their precise formulation and exceptional production quality, Lippomix was urged to manufacture these formulations in our state-of-the-art pharmaceutical facility. With fully equipped laboratories, mass production capabilities, and an extensive research library, Lippomix continually develops pharmaceutical and nutraceutical products that ensure superior delivery and absorption of this groundbreaking technology.

Showing 1 to 1 of 1 (1 Pages)